(Press-News.org)
When we think of cholera, most of us picture contaminated water and tragic outbreaks in vulnerable regions. But behind the scenes, cholera bacteria are locked in a fierce, microscopic war—one that could shape the course of pandemics.
Cholera bacteria aren’t just battling antibiotics and public health measures—they are also constantly under attack from bacteriophages (phages), viruses that infect and kill bacteria. These viruses don’t just influence individual infections; they can make or break entire epidemics. In fact, certain bacteriophages are thought to limit the size and duration of cholera outbreaks by killing off Vibrio cholerae, the bacterium behind the disease.
Since the 1960s, the ongoing 7th cholera pandemic has been driven by what are known as “seventh pandemic El Tor” (7PET) strains of V. cholerae, which have spread globally in successive waves. In this evolutionary arms race, bacteria have adapted to fight back, developing defense mechanisms against these phages. For example, many bacterial strains carry mobile genetic elements that arm them with anti-viral tools. So why are certain cholera strains so successful at evading phage attacks? Could this either enable or enhance the pathogen’s devastating effect on human populations?
One event stands out. In the early 1990s, a cholera epidemic swept through Peru and much of Latin America, infecting over 1 million people and causing thousands of deaths. The strains responsible belonged to the West African South American (WASA) lineage of V. cholerae. Why these WASA strains caused such a large outbreak in Latin America is still not fully understood.
New research by the group of Melanie Blokesch at EPFL’s Global Health Institute has now uncovered one secret behind these strains. The study, published in Nature Microbiology, shows that the WASA lineage acquired multiple distinct bacterial immune systems that have protected it from diverse types of phages. And this defense may have contributed to the massive scale of the Latin American epidemic.
The researchers looked at Peruvian cholera strains from the 1990s, testing their resistance against key phages, especially ICP1—a dominant virus that has been extensively studied in the cholera endemic area of Bangladesh where it is thought to contribute to restricting cholera outbreaks. Surprisingly, the Peruvian strains were immune to ICP1, while other strains representative of the 7th pandemic weren’t.
By deleting specific sections of the cholera strain’s DNA and inserting these genes into other bacterial strains to test their function, the team identified two major defense regions on the WASA strain’s genome, namely within the so-called WASA-1 prophage and the genomic island known as Vibrio seventh pandemic island II (VSP-II). These genomic regions encode specialized anti-phage systems that work together to create a bacterial immune system capable of defending against phage infections.
One such system, WonAB, triggers an “abortive infection” response that kills infected cells before phages can reproduce, sacrificing a few bacteria to save the larger population. This strategy is different to classical bacterial immune systems such as restriction-modification systems that degrade the phage DNA as it enters the cells. “Instead, it stops the phage from replicating but only after it has already hijacked the cholera bacterium's cellular machinery, effectively locking the infected bacteria in a standoff—but at least the phage doesn’t spread,” says David Adams, the study’s lead author.
Two further systems, GrwAB and VcSduA, contribute distinct protective functions: GrwAB targets phages with chemically modified DNA—a strategy employed by phages to camouflage their genomes and evade other bacterial immune systems. VcSduA on the other hand acts against different families of viruses including another common “vibriophage”, offering layered protection that broadens the bacterial population’s resistance spectrum.
Essentially, the WASA lineage of cholera bacteria harbors an expanded arsenal of anti-phage defense systems, which allows it to counteract a broad range of bacteriophages in addition to protection from its major predatory phage ICP1.
Understanding how epidemic bacteria resist phage predation is crucial, especially as interest in phage therapy—the use of viruses to treat bacterial infections— has re-emerged as an alternative to antibiotic treatment. If bacteria like V. cholerae can acquire increased transmission potential by obtaining viral defenses, this can reshape how we approach cholera control, monitoring, and treatment. It also underscores the importance of considering phage-bacteria dynamics when studying and managing infectious disease outbreaks.
Reference
David W. Adams, Milena Jaskólska, Alexandre Lemopoulos, Sandrine Stutzmann, Laurie Righi, Loriane Bader, Melanie Blokesch. West African South American pandemic Vibrio cholerae encodes multiple distinct phage defence systems. Nature Microbiology, 22 May 2025. DOI: 10.1038/s41564-025-02004-9
END
Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine and drug delivery, targeting a wide range of health issues.
A team led by scientists at the University of Nottingham’s School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to reveal the layers and orientation of the constituent molecules. The findings have been published today in Nature’s Mass Spectrometry Method Development collection.
Lipid nanoparticles (LNP’s) came to ...
PULLMAN, Wash. — Washington State University scientists are using microwave technology to extend the shelf life of hummus while eliminating the need for chemical preservatives, as demonstrated in a recent Journal of Food Process Engineering paper.
The Middle Eastern dip, which is growing in popularity around the world, was associated with 20 illness outbreaks in the U.S. between 2000 and 2018 that resulted in 65 hospitalizations and five deaths. Because of those outbreaks, many commercial hummus makers use chemical preservatives ...
The European Platform for Neurodegenerative Diseases (EPND) is proud to announce the release of the ATN dataset from its first biomarker case study, now accessible via the EPND Hub. This marks a major step forward in collaborative, cross-disease research tackling neurodegenerative conditions that affect millions across Europe. The release underlines EPND’s mission to foster data and biosample sharing to accelerate breakthroughs in neurodegenerative disease research.
A multi-cohort dataset to study shared disease mechanisms
The biomarker case study builds on the invaluable contributions of cohort investigators and research teams who provided biosamples ...
Richmond Hill, Canada – 6 May 2025 — Forests once hailed as reliable carbon sinks are rapidly becoming “super‑emitters” as record‑breaking wildfires sweep boreal, Amazonian, and Australian landscapes. Today’s climate policies and voluntary carbon markets seldom account for the sharp rise in fire‑driven emissions. A new publication by the United Nations University Institute for Water, Environment and Health (UNU‑INWEH), Beyond Planting Trees: Taking Advantage of Satellite Observations to Improve Forest Carbon Management and Wildfire Prevention, warns about the unintended consequences of current ...
Tokyo, Japan – Tumors are made up of millions of cells, and removing all of these cells surgically or eliminating them with medication becomes much more difficult after the cancer has spread to other parts of the body.
Now, in a study published this month in iScience, an interdisciplinary team comprising researchers from the Institute of Industrial Science, The University of Tokyo, Kanazawa University, Institute of Science Tokyo, and Kyorin University School of Medicine has determined exactly how these tumor cells are able to accomplish intrabody travel to form tumors elsewhere.
Small clusters of circulating tumor cells, which are cells that detach from tumors ...
Bone-destructive diseases such as osteoporosis and chronic inflammatory arthritis affect millions of people worldwide, causing pain, fractures, and decreased quality of life. These conditions often result from the dysregulation of osteoclasts—specialized cells responsible for breaking down bone tissue. Today, many promising treatments target the receptor activator of nuclear factor kappa B ligand (RANKL)-RANK-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling pathway, which controls ...
Knowing the molecule behind light sensitivity in migraines could open the door to better treatments
Scientists in the UK, Australia and China have identified a brain molecule called NEAT1 that appears to play a central role in triggering light sensitivity (photophobia), a common and debilitating symptom of migraines. Their findings, published in The Journal of Headache and Pain, highlight how this molecule affects the brain's pain response, contributing to the uncomfortable reaction to light that's common during migraines.
NEAT1 belongs to a group of molecules known as long noncoding RNAs. Unlike most RNA, which carries instructions for making ...
There is a strong association between an older person’s view of how they are ageing and how well they will physically recover after a fall.
That is the finding of a new research study from Imperial College London and Coventry University, which is the first to suggest how important psychological factors may be in post-fall physical recovery. The study is published in the Journal of the American Geriatrics Society.
Falls in older adults are a major health concern because they can lead to high levels of physical disability and hospitalisation, as well as affecting people’s ability to live independently. The consequences of falls in older ...
The Lancet: Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts, finds trial
In women with dense breasts (breasts with relatively low levels of fatty tissue) and a negative mammogram, supplemental imaging techniques detect early-stage cancers, with imaging techniques three times more effective than ultrasound, finds a phase 3 randomised control trial published in The Lancet.
Women with extremely dense breasts, about 10% of those aged 50-70 years in the UK, face a fourfold increased ...
People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to short-term users when they come off the medication, finds a new study led by UCL researchers.
Long-term users also tend to experience worse withdrawal symptoms, and for a longer period of time, than short-term users, and are less likely to be able to stop taking the drug when they attempt to do so, according to the findings published in Psychiatry Research.
The study’s lead author Dr Mark Horowitz, visiting clinical researcher at UCL Division of Psychiatry, said: “Our findings confirm what many researchers ...
